期刊文献+

乳头瘙痒症患者血清中部分瘙痒介质的检测与研究 被引量:1

Detection and study of itch medium level in the serum of nipple itch patients
下载PDF
导出
摘要 目的探讨乳头瘙痒症与血清中白细胞介素-2(IL-2)和白三烯B4(LTB4)水平有无关联。方法挑选经"视觉模拟标尺评分(VAS)"评估近2周内有乳头瘙痒症状的受检者38例,用双抗体夹心酶联免疫吸附法(ELISA)分析其血清IL-2和LTB4水平,对照组为38例健康者。结果乳头瘙痒症患者血清IL-2与对照组的平均值分别为(1 738.13±281.96)pg/mL和(106.93±17.35)pg/mL,两组比较差异有统计学意义(P<0.05);乳头瘙痒症患者血清LTB4与对照组的平均值分别为(94.21±15.28)ng/L和(3.17±0.50)ng/L,两组比较差异有统计学意义(P<0.05)。乳头瘙痒症患者血清IL-2水平与"痒感程度"和"痒感指数"两项指标的相关系数分别为0.718和0.689,差异有统计学意义(P<0.05);乳头瘙痒症患者血清LTB4水平与"痒感程度"和"痒感指数"两项指标的相关系数分别为0.706和0.636,差异有统计学意义(P<0.05)。结论 IL-2和LTB4在乳头瘙痒症患者体内可能作为致痒介质,参与瘙痒的发生和发展。 Objective To investigate the relevance between the nipple itch and the IL-2 and LTB-4 levels in the serum. Methods 38 patients with nipple itch evaluated by VAS in recent two weeks were selected for the study group,while 38 healthy women were selected for the control. IL-2 and LTB-4 levels were tested by using enzyme- linked immunosorbent assay (ELISA). Results The average value of the serum IL-2 level in patients and the control group were (1 738.13±281.96)pg/mL and (106.93±17.35)pg/mL,respectively (P〈0.01). And the average value of the serum LTB4 level in patients and the control group were (94.21±15.28)ng/L and (3.17 ± 0. 50)ng/L, re- spectively (P〈0.01). A positive relationship was observed between the serum IL-2 level in patients and the index of itch (r= 0.718, P〈0.01) and the itch mark (r=0. 689, P^0.01) respectively. There were the same results between the serum LTB-4 level in patients and index of itch (r=0. 706,P〈0.01) and itch mark (r=0. 636,P〈0.01) re- spectively. They were all statistically significant. Conclusion IL-2 and LTB-4 could work as the itch mediums in the occurrence and development of nipple itch in patients.
出处 《检验医学与临床》 CAS 2013年第22期2945-2946,共2页 Laboratory Medicine and Clinic
基金 广东省人口和计划生育委员会科研基金项目(2010306)
关键词 乳头瘙痒症 白细胞介素-2 白三烯B4 酶联免疫吸附法 nipple itch IL-2 LTB-4 enzyme-linked immunosorbent assay
  • 相关文献

参考文献10

  • 1Twycross R, Greaves MW, Handwerker H, et al. Itch: scratching more than the surface[J]. QJM, 2003,96 (1) 7-26.
  • 2杨文彪,蒋卫民,黄芳仪,欧阳志彬.慢性特发性荨麻疹患者瘙痒的临床特征分析[J].中国麻风皮肤病杂志,2004,20(6):544-545. 被引量:2
  • 3Wahlgren CF,Tengvall I.M, Hagermark O, et al. Itch and inflammation induced by intradermally injected interleu- kin-2 in atopic dermatitis patients and healthy subjects[J]. Arch Dermatol Res,1995,287(6):572-580.
  • 4Chi KH,Myers iN,Chow KC,et al. Phase II trial of sys- temic recombinant interleukin-2 in the treatment of refrac tory nasopharyngeal carcinoma [J] ()neology, 2001, 60 (2) = 110-115.
  • 5Stander S, Steinhoff M, Schmelz M, et al. Neurophysiolo- gy of pruritus: cutaneous elicitation of itch[J]. Arch Der- matol, 2003,139(11) : 1463-1470.
  • 6吴秋菊,马鹏程,陈志强.瘙痒介质的研究进展[J].国外医学(皮肤性病学分册),2002,28(1):25-28. 被引量:13
  • 7谢巍,周智.IL-2与CD4^+ CD25^+调节性T细胞关系研究进展[J].国外医学(内科学分册),2006,33(10):439-441. 被引量:2
  • 8徐世广,庞敏飞,吴钢锋.LTB4和IL-5在AR病情发展中的作用[J].放射免疫学杂志,2010,23(5):579-581. 被引量:3
  • 9Wenzel SE. The role o{ leukotrienes in asthma[J]. Prosta- glandins Leukot Essent Fatty Acids, 2003,69 (2): 145 155.
  • 10Wallengren J. Neuroanatomy and neurophysiology of itch [J]. Dermatol Ther, 2005,18(4) : 292 -303.

二级参考文献46

  • 1Wenzel SE.The role of leukotrienes in asthma[J].Prostaglandins Leukot Essent Fatty Acids,2003,69(2-3):145-155.
  • 2Ruzicka T, Simmet T, Peskar BA, et al. Skin levels of arachidonic acidderived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol, 1986,86(2): 105-108.
  • 3Kanai H, Nagashima A, Hirakata E, et al. The effect of azelastin hydrochloride on pruritus and leukotriene B4 in hemodialysis patients. Life Sci, 1995,57(3) :207-213.
  • 4Andoh T, Kuraishi Y. Intradermal leukotriene B4, but not prostaglandin E2, induces itch-associated responses in mice. Eur J Pharmacol, 1998,353(1) :93-96.
  • 5Andoh T, Kuraishi Y. Involvement of blockade of leukotriene B(4) action in anti-pruritic effects of emedastine in mice. Eur J Pharmacol, 2000,406(1): 149-152.
  • 6Heyer G, Vogelgsang M, Homstein OP. Acetylcholine is an inducer of itching in patients with atopic eczema. J Dermatol, 1997, 24 (10): 621-
  • 7Steen KH, Reeh PW. Actions of cholinergic agonists and antagonists on sensory nerve endings in rat skin, in vitro. J Neurophysiol, 1993,70(1 ):397-405.
  • 8Abeck D, Andersson T, Grosshans E, et al. Topical application of a platelet-activating factor (PAF) antagonist in atopic dermatitis. Acta Derm Venereol, 1997,77(6) :449-451.
  • 9Woodward DF, Nieves AL, Spada CS, et al. Characterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen.J Pharmacol Exp Ther, 1995,272(2) :758-765.
  • 10Petersen LJ, Church MK, Skor PS. Platelet-activating factor induces histamine release from human skin mast cells in vivo, which is reduced by local nerve blockade. J Allergy Clin Immunol, 1997,99(5) :640-647.

共引文献16

同被引文献17

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部